Erdheim-Chester disease in childhood: a challenging diagnosis and treatment. Tran, T. A., Fabre, M., Pariente, D., Craiu, I., Haroche, J., Charlotte, F., Eid, P., Durrbach, A., Taoufik, Y., & Kone-Paut, I. J Pediatr Hematol Oncol, 31(10):782–6, October, 2009.
Paper abstract bibtex Erdheim-Chester disease is a rare, non-Langerhans systemic histiocytosis characterized by bilateral sclerosis of the metaphyseal regions of the long bones and infiltration in other organs. The histopathologic hallmark is defined by a mononuclear infiltrate of foamy histiocytes and rare pathognomonic Touton giant cells with extensive fibrosis. This condition is exceptional in children. We report here a case of Erdheim-Chester disease in a 10-year-old girl with retroperitoneal infiltration and bone involvement, for whom the diagnosis was only established after a 3-year course with multiple biopsies. It is also the first pediatric case successfully treated with interferon-alpha suggesting that interferon-alpha can be a safe and efficient first-line therapy for this disease in children.
@article{tran_erdheim-chester_2009,
title = {Erdheim-{Chester} disease in childhood: a challenging diagnosis and treatment},
volume = {31},
issn = {1536-3678 (ELECTRONIC) 1077-4114 (LINKING)},
shorttitle = {Erdheim-{Chester} disease in childhood: a challenging diagnosis and treatment},
url = {http://www.ncbi.nlm.nih.gov/pubmed/19755920},
abstract = {Erdheim-Chester disease is a rare, non-Langerhans systemic histiocytosis characterized by bilateral sclerosis of the metaphyseal regions of the long bones and infiltration in other organs. The histopathologic hallmark is defined by a mononuclear infiltrate of foamy histiocytes and rare pathognomonic Touton giant cells with extensive fibrosis. This condition is exceptional in children. We report here a case of Erdheim-Chester disease in a 10-year-old girl with retroperitoneal infiltration and bone involvement, for whom the diagnosis was only established after a 3-year course with multiple biopsies. It is also the first pediatric case successfully treated with interferon-alpha suggesting that interferon-alpha can be a safe and efficient first-line therapy for this disease in children.},
number = {10},
journal = {J Pediatr Hematol Oncol},
author = {Tran, T. A. and Fabre, M. and Pariente, D. and Craiu, I. and Haroche, J. and Charlotte, F. and Eid, P. and Durrbach, A. and Taoufik, Y. and Kone-Paut, I.},
month = oct,
year = {2009},
keywords = {Bone, Cell, Child, Disease/*diagnosis/*drug, Diseases, Erdheim-Chester, Female, Humans, Induction, Interferon-alpha/therapeutic, Movement, Remission, Therapy, use},
pages = {782--6},
}
Downloads: 0
{"_id":"4pwSARWM38tdfHxat","bibbaseid":"tran-fabre-pariente-craiu-haroche-charlotte-eid-durrbach-etal-erdheimchesterdiseaseinchildhoodachallengingdiagnosisandtreatment-2009","author_short":["Tran, T. A.","Fabre, M.","Pariente, D.","Craiu, I.","Haroche, J.","Charlotte, F.","Eid, P.","Durrbach, A.","Taoufik, Y.","Kone-Paut, I."],"bibdata":{"bibtype":"article","type":"article","title":"Erdheim-Chester disease in childhood: a challenging diagnosis and treatment","volume":"31","issn":"1536-3678 (ELECTRONIC) 1077-4114 (LINKING)","shorttitle":"Erdheim-Chester disease in childhood: a challenging diagnosis and treatment","url":"http://www.ncbi.nlm.nih.gov/pubmed/19755920","abstract":"Erdheim-Chester disease is a rare, non-Langerhans systemic histiocytosis characterized by bilateral sclerosis of the metaphyseal regions of the long bones and infiltration in other organs. The histopathologic hallmark is defined by a mononuclear infiltrate of foamy histiocytes and rare pathognomonic Touton giant cells with extensive fibrosis. This condition is exceptional in children. We report here a case of Erdheim-Chester disease in a 10-year-old girl with retroperitoneal infiltration and bone involvement, for whom the diagnosis was only established after a 3-year course with multiple biopsies. It is also the first pediatric case successfully treated with interferon-alpha suggesting that interferon-alpha can be a safe and efficient first-line therapy for this disease in children.","number":"10","journal":"J Pediatr Hematol Oncol","author":[{"propositions":[],"lastnames":["Tran"],"firstnames":["T.","A."],"suffixes":[]},{"propositions":[],"lastnames":["Fabre"],"firstnames":["M."],"suffixes":[]},{"propositions":[],"lastnames":["Pariente"],"firstnames":["D."],"suffixes":[]},{"propositions":[],"lastnames":["Craiu"],"firstnames":["I."],"suffixes":[]},{"propositions":[],"lastnames":["Haroche"],"firstnames":["J."],"suffixes":[]},{"propositions":[],"lastnames":["Charlotte"],"firstnames":["F."],"suffixes":[]},{"propositions":[],"lastnames":["Eid"],"firstnames":["P."],"suffixes":[]},{"propositions":[],"lastnames":["Durrbach"],"firstnames":["A."],"suffixes":[]},{"propositions":[],"lastnames":["Taoufik"],"firstnames":["Y."],"suffixes":[]},{"propositions":[],"lastnames":["Kone-Paut"],"firstnames":["I."],"suffixes":[]}],"month":"October","year":"2009","keywords":"Bone, Cell, Child, Disease/*diagnosis/*drug, Diseases, Erdheim-Chester, Female, Humans, Induction, Interferon-alpha/therapeutic, Movement, Remission, Therapy, use","pages":"782–6","bibtex":"@article{tran_erdheim-chester_2009,\n\ttitle = {Erdheim-{Chester} disease in childhood: a challenging diagnosis and treatment},\n\tvolume = {31},\n\tissn = {1536-3678 (ELECTRONIC) 1077-4114 (LINKING)},\n\tshorttitle = {Erdheim-{Chester} disease in childhood: a challenging diagnosis and treatment},\n\turl = {http://www.ncbi.nlm.nih.gov/pubmed/19755920},\n\tabstract = {Erdheim-Chester disease is a rare, non-Langerhans systemic histiocytosis characterized by bilateral sclerosis of the metaphyseal regions of the long bones and infiltration in other organs. The histopathologic hallmark is defined by a mononuclear infiltrate of foamy histiocytes and rare pathognomonic Touton giant cells with extensive fibrosis. This condition is exceptional in children. We report here a case of Erdheim-Chester disease in a 10-year-old girl with retroperitoneal infiltration and bone involvement, for whom the diagnosis was only established after a 3-year course with multiple biopsies. It is also the first pediatric case successfully treated with interferon-alpha suggesting that interferon-alpha can be a safe and efficient first-line therapy for this disease in children.},\n\tnumber = {10},\n\tjournal = {J Pediatr Hematol Oncol},\n\tauthor = {Tran, T. A. and Fabre, M. and Pariente, D. and Craiu, I. and Haroche, J. and Charlotte, F. and Eid, P. and Durrbach, A. and Taoufik, Y. and Kone-Paut, I.},\n\tmonth = oct,\n\tyear = {2009},\n\tkeywords = {Bone, Cell, Child, Disease/*diagnosis/*drug, Diseases, Erdheim-Chester, Female, Humans, Induction, Interferon-alpha/therapeutic, Movement, Remission, Therapy, use},\n\tpages = {782--6},\n}\n\n\n\n","author_short":["Tran, T. A.","Fabre, M.","Pariente, D.","Craiu, I.","Haroche, J.","Charlotte, F.","Eid, P.","Durrbach, A.","Taoufik, Y.","Kone-Paut, I."],"key":"tran_erdheim-chester_2009","id":"tran_erdheim-chester_2009","bibbaseid":"tran-fabre-pariente-craiu-haroche-charlotte-eid-durrbach-etal-erdheimchesterdiseaseinchildhoodachallengingdiagnosisandtreatment-2009","role":"author","urls":{"Paper":"http://www.ncbi.nlm.nih.gov/pubmed/19755920"},"keyword":["Bone","Cell","Child","Disease/*diagnosis/*drug","Diseases","Erdheim-Chester","Female","Humans","Induction","Interferon-alpha/therapeutic","Movement","Remission","Therapy","use"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"http://bibbase.org/zotero/biblioial","dataSources":["ftoP3zPyb2N3b9Noc"],"keywords":["bone","cell","child","disease/*diagnosis/*drug","diseases","erdheim-chester","female","humans","induction","interferon-alpha/therapeutic","movement","remission","therapy","use"],"search_terms":["erdheim","chester","disease","childhood","challenging","diagnosis","treatment","tran","fabre","pariente","craiu","haroche","charlotte","eid","durrbach","taoufik","kone-paut"],"title":"Erdheim-Chester disease in childhood: a challenging diagnosis and treatment","year":2009}